Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

about

Heme oxygenase-1 promoter region (GT)n polymorphism associates with increased neuroimmune activation and risk for encephalitis in HIV infection.

P2860

Q51743775-0237067E-6CDC-4B0B-90EC-2755764E909E

P2860

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

Item

http://www.wikidata.org/entity/Q38437153

description

2016 nî lūn-bûn

@nan

2016年の論文

@ja

2016年論文

@yue

2016年論文

@zh-hant

2016年論文

@zh-hk

2016年論文

@zh-mo

2016年論文

@zh-tw

2016年论文

@wuu

2016年论文

@zh

2016年论文

@zh-cn

name

Cerebrospinal fluid interferon ...... tory HIV-Infected individuals.

@en

type

Item

label

Cerebrospinal fluid interferon ...... tory HIV-Infected individuals.

@en

prefLabel

Cerebrospinal fluid interferon ...... tory HIV-Infected individuals.

@en

P1476

Cerebrospinal fluid interferon ...... tory HIV-Infected individuals.

@en

P2093

Albert M Anderson

http://www.w3.org/2001/XMLSchema#string

Cari Kessing

http://www.w3.org/2001/XMLSchema#string

David W Loring

http://www.w3.org/2001/XMLSchema#string

Jeffrey L Lennox

http://www.w3.org/2001/XMLSchema#string

Mark M Mulligan

http://www.w3.org/2001/XMLSchema#string

Rajeth Koneru

http://www.w3.org/2001/XMLSchema#string

William R Tyor

http://www.w3.org/2001/XMLSchema#string

P2860

Cerebrospinal fluid neopterin: an informative biomarker of central nervous system immune activation in HIV-1 infection.

HIV-associated neurocognitive disorders persist in the era of potent antiretroviral therapy: CHARTER Study

Neurologic disease burden in treated HIV/AIDS predicts survival: a population-based study

Interferon-α is the primary plasma type-I IFN in HIV-1 infection and correlates with immune activation and disease markers.

Cerebrospinal fluid (CSF) neuronal biomarkers across the spectrum of HIV infection: hierarchy of injury and detection.

Interferon-alpha causes neuronal dysfunction in encephalitis.

Minocycline treatment for HIV-associated cognitive impairment: results from a randomized trial

APOE ε4 moderates abnormal CSF-abeta-42 levels, while neurocognitive impairment is associated with abnormal CSF tau levels in HIV+ individuals - a cross-sectional observational study.

Updated research nosology for HIV-associated neurocognitive disorders

Targeting the glutamatergic system for the treatment of HIV-associated neurocognitive disorders

P2888

s13365-016-0466-z

P304

106-112

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1007/S13365-016-0466-Z

http://www.w3.org/2001/XMLSchema#string

P433

http://www.w3.org/2001/XMLSchema#string

P478

http://www.w3.org/2001/XMLSchema#string

P50

Kaj Blennow

Kirk Easley

Henrik Zetterberg

P577

2016-07-11T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P698

27400930

http://www.w3.org/2001/XMLSchema#string

P921

cerebrospinal fluid

P932

5226942

http://www.w3.org/2001/XMLSchema#string

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

about

P2860

P2860

Cerebrospinal fluid interferon alpha levels correlate with neurocognitive impairment in ambulatory HIV-Infected individuals.

description

name

type

label

prefLabel

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932

P356

P1433

P1476

P2093

P2860

P2888

P304

P31

P356

P433

P478

P50

P577

P698

P921

P932